annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) for the second quarter of fiscal 2024 were $1.88, up 13.3% year over year. The metric beat the Zacks Consensus Estimate by 3.9%.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and masks with magnets field safety notification expenses, among others.
GAAP EPS in the reported quarter was $1.42, down 7.2% from the year-ago quarter.
Revenues
On a reported basis, f...
>>> Read more: ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and masks with magnets field safety notification expenses, among others.
GAAP EPS in the reported quarter was $1.42, down 7.2% from the year-ago quarter.
Revenues
On a reported basis, f...
>>> Read more: ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand
